CO 2 angiography
Iodinated contrast agents are routinely used in procedures to diagnose and treat peripheral vascular disease. Despite the development of low‐osmolar contrast agents and premedication techniques, these agents are still associated with contrast‐induced nephropathy and allergic reactions in some indivi...
Gespeichert in:
| Veröffentlicht in: | Catheterization and cardiovascular interventions 2002-03, Vol.55 (3), p.398-403 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 403 |
|---|---|
| container_issue | 3 |
| container_start_page | 398 |
| container_title | Catheterization and cardiovascular interventions |
| container_volume | 55 |
| creator | Huber, Philip R. Leimbach, Mark E. Lewis, W. Lance Marshall, J. Jeffrey |
| description | Iodinated contrast agents are routinely used in procedures to diagnose and treat peripheral vascular disease. Despite the development of low‐osmolar contrast agents and premedication techniques, these agents are still associated with contrast‐induced nephropathy and allergic reactions in some individuals. To overcome these problems, carbon dioxide angiography has been developed as an alternative to standard iodinated contrast angiography in certain patient populations. The technology of digital subtraction angiography has greatly improved the image quality of CO
2
angiography. Understanding the unique properties of CO
2
, the techniques for its use, and its associated limitations and complications will allow interventional cardiologists to expand their treatments of atherosclerotic peripheral vascular disease. Cathet Cardiovasc Intervent 2002;55:398–403. © 2002 Wiley‐Liss, Inc. |
| doi_str_mv | 10.1002/ccd.10123 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ccd_10123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_ccd_10123</sourcerecordid><originalsourceid>FETCH-LOGICAL-c743-97aaadbe894f23c75200a0e6671902f7d7132b558785836819dd51006a85e6d33</originalsourceid><addsrcrecordid>eNotj7tuAjEQRS0EUnhESv6AlmLJzHj9KqNVSJCQaCjSWYPtJSAIyK74-yyB6p7q6hwhXhHmCEBvIcQOkGRPDFERVYb0d__B6Gr9JEalHADAaXJD8dKspzTl393-vMt8-blOxKDlY0nPjx2LzeJj03xVq_XnsnlfVcHUsnKGmeM2WVe3JINRBMCQtDbogFoTDUraKmWNVVZqiy5G1QlqtirpKOVYzO63IZ9Lyan1l7w_cb56BH8r8V2J_y-Rf27gN-c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CO 2 angiography</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Huber, Philip R. ; Leimbach, Mark E. ; Lewis, W. Lance ; Marshall, J. Jeffrey</creator><creatorcontrib>Huber, Philip R. ; Leimbach, Mark E. ; Lewis, W. Lance ; Marshall, J. Jeffrey</creatorcontrib><description>Iodinated contrast agents are routinely used in procedures to diagnose and treat peripheral vascular disease. Despite the development of low‐osmolar contrast agents and premedication techniques, these agents are still associated with contrast‐induced nephropathy and allergic reactions in some individuals. To overcome these problems, carbon dioxide angiography has been developed as an alternative to standard iodinated contrast angiography in certain patient populations. The technology of digital subtraction angiography has greatly improved the image quality of CO
2
angiography. Understanding the unique properties of CO
2
, the techniques for its use, and its associated limitations and complications will allow interventional cardiologists to expand their treatments of atherosclerotic peripheral vascular disease. Cathet Cardiovasc Intervent 2002;55:398–403. © 2002 Wiley‐Liss, Inc.</description><identifier>ISSN: 1522-1946</identifier><identifier>EISSN: 1522-726X</identifier><identifier>DOI: 10.1002/ccd.10123</identifier><language>eng</language><ispartof>Catheterization and cardiovascular interventions, 2002-03, Vol.55 (3), p.398-403</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c743-97aaadbe894f23c75200a0e6671902f7d7132b558785836819dd51006a85e6d33</citedby><cites>FETCH-LOGICAL-c743-97aaadbe894f23c75200a0e6671902f7d7132b558785836819dd51006a85e6d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27906,27907</link.rule.ids></links><search><creatorcontrib>Huber, Philip R.</creatorcontrib><creatorcontrib>Leimbach, Mark E.</creatorcontrib><creatorcontrib>Lewis, W. Lance</creatorcontrib><creatorcontrib>Marshall, J. Jeffrey</creatorcontrib><title>CO 2 angiography</title><title>Catheterization and cardiovascular interventions</title><description>Iodinated contrast agents are routinely used in procedures to diagnose and treat peripheral vascular disease. Despite the development of low‐osmolar contrast agents and premedication techniques, these agents are still associated with contrast‐induced nephropathy and allergic reactions in some individuals. To overcome these problems, carbon dioxide angiography has been developed as an alternative to standard iodinated contrast angiography in certain patient populations. The technology of digital subtraction angiography has greatly improved the image quality of CO
2
angiography. Understanding the unique properties of CO
2
, the techniques for its use, and its associated limitations and complications will allow interventional cardiologists to expand their treatments of atherosclerotic peripheral vascular disease. Cathet Cardiovasc Intervent 2002;55:398–403. © 2002 Wiley‐Liss, Inc.</description><issn>1522-1946</issn><issn>1522-726X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNotj7tuAjEQRS0EUnhESv6AlmLJzHj9KqNVSJCQaCjSWYPtJSAIyK74-yyB6p7q6hwhXhHmCEBvIcQOkGRPDFERVYb0d__B6Gr9JEalHADAaXJD8dKspzTl393-vMt8-blOxKDlY0nPjx2LzeJj03xVq_XnsnlfVcHUsnKGmeM2WVe3JINRBMCQtDbogFoTDUraKmWNVVZqiy5G1QlqtirpKOVYzO63IZ9Lyan1l7w_cb56BH8r8V2J_y-Rf27gN-c</recordid><startdate>200203</startdate><enddate>200203</enddate><creator>Huber, Philip R.</creator><creator>Leimbach, Mark E.</creator><creator>Lewis, W. Lance</creator><creator>Marshall, J. Jeffrey</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200203</creationdate><title>CO 2 angiography</title><author>Huber, Philip R. ; Leimbach, Mark E. ; Lewis, W. Lance ; Marshall, J. Jeffrey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c743-97aaadbe894f23c75200a0e6671902f7d7132b558785836819dd51006a85e6d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huber, Philip R.</creatorcontrib><creatorcontrib>Leimbach, Mark E.</creatorcontrib><creatorcontrib>Lewis, W. Lance</creatorcontrib><creatorcontrib>Marshall, J. Jeffrey</creatorcontrib><collection>CrossRef</collection><jtitle>Catheterization and cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huber, Philip R.</au><au>Leimbach, Mark E.</au><au>Lewis, W. Lance</au><au>Marshall, J. Jeffrey</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CO 2 angiography</atitle><jtitle>Catheterization and cardiovascular interventions</jtitle><date>2002-03</date><risdate>2002</risdate><volume>55</volume><issue>3</issue><spage>398</spage><epage>403</epage><pages>398-403</pages><issn>1522-1946</issn><eissn>1522-726X</eissn><abstract>Iodinated contrast agents are routinely used in procedures to diagnose and treat peripheral vascular disease. Despite the development of low‐osmolar contrast agents and premedication techniques, these agents are still associated with contrast‐induced nephropathy and allergic reactions in some individuals. To overcome these problems, carbon dioxide angiography has been developed as an alternative to standard iodinated contrast angiography in certain patient populations. The technology of digital subtraction angiography has greatly improved the image quality of CO
2
angiography. Understanding the unique properties of CO
2
, the techniques for its use, and its associated limitations and complications will allow interventional cardiologists to expand their treatments of atherosclerotic peripheral vascular disease. Cathet Cardiovasc Intervent 2002;55:398–403. © 2002 Wiley‐Liss, Inc.</abstract><doi>10.1002/ccd.10123</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1522-1946 |
| ispartof | Catheterization and cardiovascular interventions, 2002-03, Vol.55 (3), p.398-403 |
| issn | 1522-1946 1522-726X |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_ccd_10123 |
| source | Wiley Online Library Journals Frontfile Complete |
| title | CO 2 angiography |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A59%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CO%202%20angiography&rft.jtitle=Catheterization%20and%20cardiovascular%20interventions&rft.au=Huber,%20Philip%20R.&rft.date=2002-03&rft.volume=55&rft.issue=3&rft.spage=398&rft.epage=403&rft.pages=398-403&rft.issn=1522-1946&rft.eissn=1522-726X&rft_id=info:doi/10.1002/ccd.10123&rft_dat=%3Ccrossref%3E10_1002_ccd_10123%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |